Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
SEPN
Septerna, Inc.
CAPPED RATING
Septerna, Inc. (SEPN) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B); its weakest is Growth (D-). The rating has held at C for 5 weeks.
Quantitative Factor Evaluation • Updated
Overall Rating
2.2
/ 5.0
C
Value
B-
Factor Score
2.9
/ 5.0
Growth
D-
Factor Score
1.0
/ 5.0
Profitability
C
Factor Score
2.3
/ 5.0
Momentum
B
Factor Score
3.4
/ 5.0
Revisions
D+
Factor Score
1.5
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-25.5
EV / EBITDA
-21.4
Rev Growth YoY
-12.2%
Gross Margin
N/M
Price Return 3M
-3.6%
Price Return 12M
121.5%
Catalyst Signal
0.00
Market Cap
$2.0B
TTM Revenue
$96.3M
Price / Sales
21.0
ROE
-14.4%
Historical Factor Score Progression
Held C for 5 weeks
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-14 | B- (2.9) | D- (1.0) | C (2.3) | B (3.4) | D+ (1.5) | C (2.2) |
| 2026-11-07 | B- (2.9) | D- (0.7) | C (2.3) | A- (4.0) | D+ (1.5) | C (2.3) |
| 2026-10-31 | B- (2.9) | D- (0.7) | C (2.3) | A- (4.1) | D+ (1.5) | C (2.3) |
| 2026-10-24 | B- (2.9) | D- (0.7) | B (3.3) | A- (3.9) | D+ (1.6) | C (2.5) |
| 2026-10-17 | B- (2.9) | D- (0.7) | B (3.3) | B+ (3.8) | D+ (1.5) | C (2.4) |
Page
1
of
4